The shifting UK landscape surrounding entheogens is increasingly complex, demanding careful exploration. While clinical research into compounds like psilocybin and copyright continues to advance, and patient availability via private clinics is growing, the regulatory framework remains unclear. This presents a unique situation for both patients i… Read More